News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
149 Results
Section
Business (18)
Deals (5)
Drug Development (25)
FDA (2)
News (48)
Tag
ADA (2)
Approvals (2)
Cancer (1)
Cardiovascular disease (3)
Clinical research (35)
Collaboration (1)
Compensation (7)
Data (11)
Diabetes (19)
Earnings (21)
Events (54)
FDA (3)
GLP-1 (8)
Healthcare (1)
IPO (5)
Metabolic disorders (19)
Obesity (2)
Patient recruitment (2)
People (6)
Phase 1 (14)
Phase 2 (22)
Pipeline (9)
Preclinical (10)
Regulatory (2)
Date
Last 30 days (1)
Last 365 days (29)
2026 (11)
2025 (32)
2024 (30)
2023 (31)
2022 (32)
2021 (13)
Location
California (59)
Northern California (58)
United States (59)
149 Results for "biomeafusion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion to Participate at Upcoming Investor Conferences - May 12, 2026
May 13, 2026
·
1 min read
Press Releases
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions
May 6, 2026
·
2 min read
Press Releases
Biomea Fusion to Participate at Upcoming Investor Conferences - February 19, 2026
February 19, 2026
·
1 min read
Press Releases
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
June 3, 2026
·
9 min read
Press Releases
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
April 28, 2026
·
11 min read
Press Releases
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
June 7, 2026
·
12 min read
Press Releases
Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026
·
10 min read
Press Releases
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
March 15, 2026
·
10 min read
Press Releases
Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series
October 21, 2025
·
1 min read
1 of 15
Next
